Unraveling the Mystery: A Comprehensive Approach to Diagnosing and Managing Chronic Cough in Clinical Practice
OthersPage Navigation
Introduction
Chronic cough, defined as a cough lasting more than eight weeks, is a common yet challenging condition to manage in clinical practice. Despite its prevalence, the etiological factors and effective management strategies remain enigmatic.
Etiological Factors
Chronic cough is frequently associated with conditions such as asthma, gastroesophageal reflux disease (GERD), and postnasal drip syndrome (PNDS). However, it can also be a symptom of less common diseases such as lung cancer, tuberculosis, and sarcoidosis.
Diagnostic Approach
A comprehensive diagnostic approach should include a detailed patient history, physical examination, and appropriate investigations. The use of diagnostic tools such as chest X-rays, spirometry, and bronchoscopy can aid in identifying the underlying cause.
Management Strategies
Management should be tailored according to the identified cause. For instance, GERD-associated cough may respond to proton pump inhibitors, while PNDS may require antihistamines or corticosteroids. In refractory cases, a multidisciplinary approach involving pulmonologists, gastroenterologists, and otolaryngologists may be necessary.
Conclusion
Unraveling the mystery of chronic cough requires a comprehensive, patient-centered approach. By understanding the potential etiological factors and employing appropriate diagnostic and management strategies, clinicians can effectively address this challenging condition.
Recommended News For You
Recommended Articles For You
Featured News
Featured Articles
Featured Events
Featured KOL Videos
1.
Prostate cancer detection with PET CT and PET MRI is comparable.
2.
Refractory Multiple Myeloma Responsive to Immunotherapy Plus Low-Dose Radiotherapy
3.
AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns
4.
In NSCLC, subcutaneous Lazertinib + Amivantamab Dosing Is Not Worse Than IV Dosing.
5.
Loncastuximab-Rituximab Boosts Response Rates in R/R Follicular Lymphoma
1.
Innovative Intraoperative Therapies in Neurosurgical Oncology: Advancing Precision and Outcomes
2.
Unlocking the Potential of Bicalutamide 50 mg: A Revolutionary New Treatment for Prostate Cancer
3.
Holistic Oncology: Advancing Survivorship, Nursing, and Innovative Cancer Care Models
4.
Emerging Chemo-Immunotherapy: New Agents and Mechanisms in Modern Oncology
5.
The Dangers of Supratherapeutic INR: The Need for Increased Awareness and Monitoring
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Thromboprophylaxis In Medical Settings
2.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC
4.
Efficient Management of First line ALK-rearranged NSCLC
5.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Welcome to Hidoc Dr.
Join to enhance your clinical skills and gain specialized in-depth medical knowledge